Penn Medicine
Help | Search | Site Map | Contact   
faculty photo

Tara C Gangadhar, MD

Assistant Professor of Medicine at the Hospital of the University of Pennsylvania
Teaching Attending, Penn Internal Medicine Oncology inpatient rotation for residents, interns and medical students., University of Pennsylvania
Department: Medicine

Contact information
Division of Hematology Oncology
Perelman Center for Advanced Medicine
10th Floor, South Pavilion
Office #10-202
3400 Civic Center Blvd.
South Pavilion, 7th Floor
Philadelphia, PA 19104
Office: 215-662-7907
Fax: 215-662-4646
Education:
BA (Anthropology)
Columbia University, 2000.
MD (Internal Medicine)
New York University School of Medicine, 2004.
Post-Graduate Training
Intern in Internal Medicine, Indiana University Medical Center, 2004-2005.
Resident in Internal Medicine , Indiana University Medical Center, 2005-2007.
Fellow in Hematology/Oncology, The University of Chicago, 2007-2011.
Fellow in Clinical Pharmacology and Pharmacogenomics, The University of Chicago , 2009-2011.
Certifications
American Board of Internal Medicine (Internal Medicine), 2007.
American Board of Internal Medicine (Medical Oncology), 2010.
American Board of Clinical Pharmacology (Clinical Pharmacology), 2011.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Description of Clinical Expertise

Melanoma
Cutaneous malignancies
Gastroinitestinal malignancies

Description of Research Expertise

Melanoma
Immune therpay
Targeted therapy
Phase I trials
Combination therapy
Experimental therapeutics
Pharmacology

Selected Publications

Hodi F Stephen, Hwu Wen-Jen, Kefford Richard, Weber Jeffrey S, Daud Adil, Hamid Omid, Patnaik Amita, Ribas Antoni, Robert Caroline, Gangadhar Tara C, Joshua Anthony M, Hersey Peter, Dronca Roxana, Joseph Richard, Hille Darcy, Xue Dahai, Li Xiaoyun Nicole, Kang S Peter, Ebbinghaus Scot, Perrone Andrea, Wolchok Jedd D: Evaluation of Immune-Related Response Criteria and RECIST v1.1 in Patients With Advanced Melanoma Treated With Pembrolizumab. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 34(13): 1510-7, May 2016.

Ribas Antoni, Hamid Omid, Daud Adil, Hodi F Stephen, Wolchok Jedd D, Kefford Richard, Joshua Anthony M, Patnaik Amita, Hwu Wen-Jen, Weber Jeffrey S, Gangadhar Tara C, Hersey Peter, Dronca Roxana, Joseph Richard W, Zarour Hassane, Chmielowski Bartosz, Lawrence Donald P, Algazi Alain, Rizvi Naiyer A, Hoffner Brianna, Mateus Christine, Gergich Kevin, Lindia Jill A, Giannotti Maxine, Li Xiaoyun Nicole, Ebbinghaus Scot, Kang S Peter, Robert Caroline: Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced Melanoma. JAMA 315(15): 1600-9, Apr 2016.

Zhang Gao, Frederick Dennie T, Wu Lawrence, Wei Zhi, Krepler Clemens, Srinivasan Satish, Chae Young Chan, Xu Xiaowei, Choi Harry, Dimwamwa Elaida, Ope Omotayo, Shannan Batool, Basu Devraj, Zhang Dongmei, Guha Manti, Xiao Min, Randell Sergio, Sproesser Katrin, Xu Wei, Liu Jephrey, Karakousis Giorgos C, Schuchter Lynn M, Gangadhar Tara C, Amaravadi Ravi K, Gu Mengnan, Xu Caiyue, Ghosh Abheek, Xu Weiting, Tian Tian, Zhang Jie, Zha Shijie, Liu Qin, Brafford Patricia, Weeraratna Ashani, Davies Michael A, Wargo Jennifer A, Avadhani Narayan G, Lu Yiling, Mills Gordon B, Altieri Dario C, Flaherty Keith T, Herlyn Meenhard: Targeting mitochondrial biogenesis to overcome drug resistance to MAPK inhibitors. The Journal of clinical investigation Apr 2016.

Shannan Batool, Chen Quan, Watters Andrea, Perego Michela, Krepler Clemens, Thombre Rakhee, Li Ling, Rajan Geena, Peterson Scott, Gimotty Phyllis A, Wilson Melissa, Nathanson Katherine L, Gangadhar Tara C, Schuchter Lynn M, Weeraratna Ashani T, Herlyn Meenhard, Vultur Adina: Enhancing the evaluation of PI3K inhibitors through 3D melanoma models. Pigment cell & melanoma research 29(3): 317-28, Feb 2016.

Dizon Don S, Krilov Lada, Cohen Ezra, Gangadhar Tara, Ganz Patricia A, Hensing Thomas A, Hunger Stephen, Krishnamurthi Smitha S, Lassman Andrew B, Markham Merry Jennifer, Mayer Erica, Neuss Michael, Pal Sumanta Kumar, Richardson Lisa C, Schilsky Richard, Schwartz Gary K, Spriggs David R, Villalona-Calero Miguel Angel, Villani Gina, Masters Gregory: Clinical Cancer Advances 2016: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 34(9): 987-1011, Feb 2016.

Shah Nirav N, Casella Erica, Capozzi Donna, McGettigan Suzanne, Gangadhar Tara C, Schuchter Lynn, Myers Jennifer S: Improving the Safety of Oral Chemotherapy at an Academic Medical Center. Journal of oncology practice / American Society of Clinical Oncology 12(1): e71-6, Jan 2016.

Shin Thuzar M, Gangadhar Tara, Miller Christopher J: Treatment options for metastatic melanoma in solid organ transplant recipients. JAAD case reports 1(6): S26-8, Nov 2015.

Sholl Lynette M, Andea Aleodor, Bridge Julia A, Cheng Liang, Davies Michael A, Ehteshami Mani, Gangadhar Tara C, Kamel-Reid Suzanne, Lazar Alexander, Raparia Kirtee, Siroy Alan, Watson Kimberly L: Template for Reporting Results of Biomarker Testing of Specimens From Patients With Melanoma. Archives of pathology & laboratory medicine 140(4): 355-7, Sep 2015.

Ribas Antoni, Puzanov Igor, Dummer Reinhard, Schadendorf Dirk, Hamid Omid, Robert Caroline, Hodi F Stephen, Schachter Jacob, Pavlick Anna C, Lewis Karl D, Cranmer Lee D, Blank Christian U, O'Day Steven J, Ascierto Paolo A, Salama April K S, Margolin Kim A, Loquai Carmen, Eigentler Thomas K, Gangadhar Tara C, Carlino Matteo S, Agarwala Sanjiv S, Moschos Stergios J, Sosman Jeffrey A, Goldinger Simone M, Shapira-Frommer Ronnie, Gonzalez Rene, Kirkwood John M, Wolchok Jedd D, Eggermont Alexander, Li Xiaoyun Nicole, Zhou Wei, Zernhelt Adriane M, Lis Joy, Ebbinghaus Scot, Kang S Peter, Daud Adil: Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial. The Lancet. Oncology 16(8): 908-18, Aug 2015.

Gangadhar Tara C, Schuchter Lynn M: Broad Applicability of Nivolumab in Melanoma Regardless of BRAF Mutation Status. JAMA oncology 1(4): 427-8, Jul 2015.

back to top
Last updated: 07/14/2016
The Trustees of the University of Pennsylvania
 
© The Trustees of the University of Pennsylvania. Site best viewed with Mozilla, NN, IE, or Safari.
SOM Home International Programs Penn Alumni Clinical Trials Centers and Institutes Departments Faculty Research Education Administration